Pharmatech

With the latest EU IDMP guidance now published, pharma companies must now measure their readiness for the new world, in which data-based regulatory submissions run parallel with, and will ultimately replace, single-use documents. Here, Adnan Jamil, a Senior Consultant at data-driven life sciences transformation specialist, Iperion, offers step-by-step advice to pharma companies keen to reap […]

A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare diseases potentially the biggest beneficiaries of positive Covid-19 legacies – including accelerated development timelines, remote trials and new technologies in genetic and target screening. The report anticipates breakthroughs in multi-modal disease therapies within five […]

Clinical pharmatech company Exscientia’s Series C financing round was completed with investment of $30 million from BlackRock, which will accelerate its AI drug discovery platform and pipeline. Blackrock funds joined Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital in the investment $100 million round. New capital will be used to support Exscientia’s platform […]